Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700921 · ClinicalTrials.gov registry record · Phase 2
Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2 study, sponsored by National Jewish Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00700921 is a Phase 2 study that has completed, run by National Jewish Health. The registered enrollment target is 30 participants.
The verdict
NCT00700921, a Phase 2 study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will test whether lovastatin helps to modify lung inflammation in patients with COPD (Chronic Obstructive Pulmonary Disease).
Interventions
- DRUG Placebo
- DRUG Lovastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00700921
The ClinicalTrials.gov registry entry for NCT00700921 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00700921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00700921 about?
NCT00700921 is a clinical study titled "Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)". This study will test whether lovastatin helps to modify lung inflammation in patients with COPD (Chronic Obstructive Pulmonary Disease).
What is the current status of trial NCT00700921?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00700921?
The interventions under investigation include: Placebo (DRUG), Lovastatin (DRUG).
Who is sponsoring clinical trial NCT00700921?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.